These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 10456135)

  • 1. Evaluation of lacidipine (a calcium blocker) in the treatment of hypertension in black African people: a double-blind comparison with hydrochlorothiazide.
    Salako BL; Kadiri S; Walker O; Fehintola FA
    Afr J Med Med Sci; 1998; 27(1-2):73-5. PubMed ID: 10456135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lacidipine, hydrochlorothiazide and their combination in systolic hypertension in the elderly.
    Wing LM; Arnolda LF; Harvey PJ; Upton J; Molloy D; Bune AJ; Chalmers JP
    J Hypertens; 1997 Dec; 15(12 Pt 1):1503-10. PubMed ID: 9431858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of lacidipine on patients with mild to moderate hypertension and the effect of a combination of lacidipine and hydrochlorothiazide in the treatment of hypertension uncontrolled after four weeks of lacidipine treatment: an open study.
    Okeahialam BN; Isamade EI; Ibrahim TM; Anjorin FI
    West Afr J Med; 1998; 17(1):42-6. PubMed ID: 9643160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double-blind comparison of the efficacy and safety of lacidipine and hydrochlorothiazide in essential hypertension. The Southern Italy Lacidipine Study Group.
    Chiariello M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S35-7. PubMed ID: 1726004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of lercanidipine versus hydrochlorothiazide as add-on to enalapril in diabetic populations with uncontrolled hypertension.
    Agrawal R; Marx A; Haller H
    J Hypertens; 2006 Jan; 24(1):185-92. PubMed ID: 16331117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additive hypotensive effect of a dihydropyridine calcium antagonist to that produced by a thiazide diuretic: a double-blind placebo-controlled crossover trial with ambulatory blood pressure monitoring.
    Stergiou GS; Malakos JS; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):412-6. PubMed ID: 9125681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the effects on blood pressure and left ventricular hypertrophy of lacidipine and hydrochlorothiazide in hypertensive patients.
    Leonetti G; Fogari R; Mazzola C; Mangiameli S; Castello C
    J Hypertens Suppl; 1991 Dec; 9(3):S29-31. PubMed ID: 1839161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebral perfusion in hypertensive patients: effects of lacidipine and hydrochlorothiazide.
    Semplicini A; Maresca A; Simonella C; Carollo C; Chierichetti F; Santipolo N; Pauletto P; Ferlin G; Pessina AC
    J Cardiovasc Pharmacol; 2000; 35(3 Suppl 1):S13-8. PubMed ID: 11347856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial.
    Association of Black Cardiologists (ABC) Candesartan Study Group
    Heart Dis; 2000; 2(6):392-9. PubMed ID: 11728289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension.
    Fogari R; Zoppi A; Corradi L; Preti P; Malalamani GD; Mugellini A
    J Hypertens; 2000 Dec; 18(12):1871-5. PubMed ID: 11132613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of the efficacy and safety of lacidipine with atenolol in the treatment of essential hypertension. The United Kingdom Lacidipine Study Group.
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S27-30. PubMed ID: 1726002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intervention at lower blood pressure levels to achieve target goals in type 2 diabetes: PRADID (PResión Arterial en DIabéticos tipo Dos) study.
    Ruilope LM; Usan L; Segura J; Bakris GL
    J Hypertens; 2004 Jan; 22(1):217-22. PubMed ID: 15106814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of manidipine/delapril versus olmesartan/hydrochlorothiazide combination therapy in elderly hypertensive patients with type 2 diabetes mellitus.
    Fogari R; Derosa G; Zoppi A; Rinaldi A; Preti P; Lazzari P; Mugellini A
    Hypertens Res; 2008 Jan; 31(1):43-50. PubMed ID: 18360017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-acting lacidipine versus short-acting nifedipine in the treatment of asymptomatic acute blood pressure increase.
    Sánchez M; Sobrino J; Ribera L; Adrián MJ; Torres M; Coca A
    J Cardiovasc Pharmacol; 1999 Mar; 33(3):479-84. PubMed ID: 10069685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR; Bryson HM
    Drugs; 1994 Aug; 48(2):274-96. PubMed ID: 7527328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical position of lacidipine, a new dihydropyridine calcium antagonist, in the treatment of hypertension.
    Leonetti G
    J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S18-21. PubMed ID: 1725445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind study.
    Lau CP; Cheung BM
    J Cardiovasc Pharmacol; 1996 Aug; 28(2):328-31. PubMed ID: 8856491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term, open-label evaluation of the safety and efficacy of telmisartan 80 mg/hydrochlorothiazide 25 mg fixed-dose combination alone or with other antihypertensive medication.
    Neldam S; Edwards C
    Expert Opin Pharmacother; 2009 Feb; 10(3):345-52. PubMed ID: 19191674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ambulatory blood pressure response to triple therapy with an angiotensin-receptor blocker (ARB), calcium-channel blocker (CCB), and HCTZ versus dual therapy with an ARB and HCTZ.
    Duprez D; Ferdinand K; Purkayastha D; Samuel R; Wright R
    Vasc Health Risk Manag; 2011; 7():701-8. PubMed ID: 22174580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with olmesartan medoxomil and hydrochlorothiazide: secondary analysis of the proportion of patients achieving recommended blood pressure goals from a randomized, double-blind, factorial study.
    Chrysant SG; Chavanu KJ; Xu J
    Am J Cardiovasc Drugs; 2009; 9(4):241-51. PubMed ID: 19655819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.